Found 930 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
This is an open-label, multicenter, Phase 1b/2 study to determine the safety and tolerability of IMGN632 and assess the antileukemia activity of IMGN632 when administered in combination with azacitidine and/or venetoclax in participants with relapsed and frontline CD123-positive AML. We would like to rely on Advarra IRB as the IRB …
Please refer to Protocol Section 3. (OBJECTIVES AND ENDPOINTS). Please refer to Protocol Section 3. (OBJECTIVES AND ENDPOINTS). Please refer to Protocol Section 3. (OBJECTIVES AND ENDPOINTS).
Medtronic DBS Therapy for Dystonia delivers electrical stimulation to areas of your brain to help control symptoms of various movement disorders. N/A N/A
Determine safety and tolerability of IV administered doses of CMTX-101. Determine safety and tolerability of IV administered doses of CMTX-101. Assess the PK of different doses of CMTX-101. Evaluate immunogenicity (i.e., development of anti-drug antibodies [ADA] and neutralizing antibodies [Nabs]) of a single IV administered dose of CMTX-101. Assess the …
Please refer to Protocol Section 2 (Objectives and Endpoints). Please refer to Protocol Section 2 (Objectives and Endpoints). Please refer to Protocol Section 2 (Objectives and Endpoints).
Primary Objective: To compare the efficacy of 2 doses of BHV-7000 to placebo as an adjunctive therapy for refractory focal onset epilepsy as measured by the change from baseline in 28-day average seizure frequency. Secondary Objcetives: -To compare the efficacy of 2 doses of BHV-7000 to placebo as adjunctive therapy …
To examine the effects of ketone supplement, Kenetik (KS) three times daily (TID), verse placebo, on the need for benzodiazepines and CIWA scores, while undergoing in-patient acute withdrawal management.To test the effects of Ketone Supplementation (KS) Kenetik in reducing alcohol withdrawal signs and symptoms and the need for medications to …
Please refer to Protocol Section 3 (Objectives and Endpoints). Please refer to Protocol Section 3 (Objectives and Endpoints). Please refer to Protocol Section 3 (Objectives and Endpoints).
Please refer to Protocol Section 2 (Study Objectives). Please refer to Protocol Section 15.1 (Study Design/Endpoints). Please refer to Protocol Section 15.1 (Study Design/Endpoints).
The purpose of this study is to investigate the cause of brain’s reduced control of muscles in the arm after stroke. We will use brain sensors (EEG) and muscle sensors (EMG) to understand the transfer of information from the brain to the muscles in the arm. We will also study the readiness potential which is a …
